These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26438592)

  • 1. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.
    Fabian CJ; Kimler BF; Phillips TA; Box JA; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
    Cancer Prev Res (Phila); 2015 Oct; 8(10):912-21. PubMed ID: 26438592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.
    Fabian CJ; Kimler BF; Phillips TA; Nydegger JL; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
    Cancer Prev Res (Phila); 2015 Oct; 8(10):922-31. PubMed ID: 26276744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
    Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
    Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 and omega-6 Fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology.
    Hidaka BH; Li S; Harvey KE; Carlson SE; Sullivan DK; Kimler BF; Zalles CM; Fabian CJ
    Cancer Prev Res (Phila); 2015 May; 8(5):359-64. PubMed ID: 25712053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo.
    Fabian CJ; Befort CA; Phillips TA; Nydegger JL; Kreutzjans AL; Powers KR; Metheny T; Klemp JR; Carlson SE; Sullivan DK; Zalles CM; Giles ED; Hursting SD; Hu J; Kimler BF
    Cancer Prev Res (Phila); 2021 Sep; 14(9):893-904. PubMed ID: 34244155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.
    Fabian CJ; Kimler BF; Zalles CM; Phillips TA; Metheny T; Petroff BK; Havighurst TC; Kim K; Bailey HH; Heckman-Stoddard BM
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1146-55. PubMed ID: 26391916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
    Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
    Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention.
    Fabian CJ; Kimler BF
    Am Soc Clin Oncol Educ Book; 2013; ():97-101. PubMed ID: 23714467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of omega-3 levels in serum phospholipid from 2053 human blood samples with key fatty acid ratios.
    Holub BJ; Wlodek M; Rowe W; Piekarski J
    Nutr J; 2009 Dec; 8():58. PubMed ID: 20034401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
    J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle-Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study.
    Kobayashi Y; Fujikawa T; Haruna A; Kawano R; Ozawa M; Haze T; Komiya S; Suzuki S; Ohki Y; Fujiwara A; Saka S; Hirawa N; Toya Y; Tamura K
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256336
    [No Abstract]   [Full Text] [Related]  

  • 15. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
    Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.
    Gucalp A; Zhou XK; Cook ED; Garber JE; Crew KD; Nangia JR; Bhardwaj P; Giri DD; Elemento O; Verma A; Wang H; Lee JJ; Vornik LA; Mays C; Weber D; Sepeda V; O'Kane H; Krasne M; Williams S; Morris PG; Heckman-Stoddard BM; Dunn BK; Hudis CA; Brown PH; Dannenberg AJ
    Cancer Prev Res (Phila); 2018 Apr; 11(4):203-214. PubMed ID: 29453232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.
    Flock MR; Skulas-Ray AC; Harris WS; Gaugler TL; Fleming JA; Kris-Etherton PM
    Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):161-8. PubMed ID: 25091379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.